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To directly determine whether the RISC is involved in the toxicity, we introduced CD95L into 138 CD95 k.o. HeyA8 cells after knocking down AGO2 ( Figure 3B ). Knock down of AGO2 was 139 efficient (insert in Figure 3B ). Toxicity elicited by CD95L was severely blunted following 140 AGO2 knockdown, suggesting that AGO2 was required for CD95L mRNA to be toxic. 141
To test the hypothesis that Drosha k.o. cells were more sensitive because their RISC was not 142
occupied by large amounts of nontoxic miRNAs and to determine whether CD95L mRNA could 143
give rise to small RNAs that incorporate into the RISC, we pulled down AGO1-4-associated 144
RNAs and analyzed their composition in wt and Drosha k.o. cells after expressing the 145
CD95L
MUT NP mRNA. For the pull-down, we used a peptide-derived from the AGO-binding 146 partner GW182-recently described to bind to all four Ago proteins (Hauptmann et al., 2015) . 147
As expected in wt HCT116 cells, large amounts of small RNAs (19-23nt in length) were detected 148 bound to the Ago proteins ( Figure 3C ). Both AGO1 and AGO2 were efficiently pulled down. In 149 contrast, in the Drosha k.o. cells, which cannot generate canonical miRNAs, only a low amount 150 of small RNAs was detected, confirming the absence of miRNAs in the RISC. Surprisingly, the 151 amount of pulled down Ago proteins was severely reduced despite the fact these Drosha k.o. 152 cells express comparable levels of AGO2 (Putzbach et al., 2017) . This suggests the peptide did 153 not have access to the Ago proteins in Drosha k.o. cells, presumably because it only binds to Ago 154 proteins complexed with RNA as recently shown (Elkayam et al., 2017) . 155
The analysis of all Ago-bound RNAs showed that in the wt cells, >98.4% of bound RNAs 156 were miRNAs. In contrast, only 34% of bound RNAs were miRNAs in Drosha k.o. cells ( Figure  157 3D and data not shown). These include miRNAs that are processed independently of Drosha 158 such as miR-320a (Kim, Kim, & Kim, 2016) . Consistently, this miRNA became a major RNA 159 species bound to Ago proteins in Drosha k.o. cells ( Figure 3D ). In both wt and Drosha k.o. cells, 160 a significant increase in CD95L-derived small RNAs bound to the Ago proteins was detected 161 compared to cells infected with pLenti empty vector. They corresponded to 0.0006% and 0.043% 162 of all the Ago-bound RNAs in the wt cells and Drosha k.o. cells, respectively. Toxicity of 163 CD95L mRNA was, therefore, not due to overloading the RISC. In the absence of most 164 miRNAs, the total amount of RNAs bound to Ago proteins in the Drosha k.o. cells was roughly 165 10% of the amount bound to Ago in wt cells ( Figure 3D ). The reduction of Ago-bound miRNAs 166 in Drosha k.o. cells ( Figure 3E , top row) was paralleled by a substantial increase in binding of 167 other small RNAs to the Ago proteins ( Figure 3E , bottom row). Interestingly, the amount of 168
Ago-bound CD95L-derived small RNAs was >100 times higher in the Drosha k.o. cells7 compared to the wt cells (red columns in Figure 3E ). These data support our hypothesis that 170 Drosha k.o. cells are more sensitive to CD95L mRNA-mediated toxicity due to their ability to 171 take up more toxic small CD95L-derived RNAs into the RISC in the absence of most miRNAs. 172 173 CD95L ORF is degraded into small RNA fragments that are then loaded into the RISC. 174
Interestingly, not only did Ago proteins in Drosha k.o. cells bind much more CD95L-derived 175 small RNAs than in the wt cells, but also the peak length of the most abundant Ago-bound RNA 176 species increased from 20 to 23 nt ( Figure 4A, top panel) . To determine the sites within the 177 CD95L mRNA that gave rise to small Ago-bound RNAs, we aligned all small Ago-bound RNAs 178 detected in all conditions to the CD95L ORF sequence (Figure 4B and C) . We identified 22 179 regions in the CD95L ORF that gave rise to small RNAs that could be bound by Ago proteins 180 ( Figure 4B ). To determine whether these small RNAs were formed in the cytosol and then 181 loaded into the RISC, we also aligned all small RNAs in the total RNA fraction isolated from 182
MUT NP expressing HCT116 Drosha k.o. cells with CD95L ( Figure 4C ). Interestingly, 183 very similar regions of small RNAs were found. Moreover, the mean as well as the peak of the 184 distribution of the read lengths of small RNAs bound to Ago proteins was smaller than in the 185 total small RNAs fraction ( Figure 4A , center panel), suggesting these fragments were trimmed 186 to the appropriate length either right before they are loaded into the RISC or by the RISC itself. 187
This was most obvious for the small RNAs in cluster 3 (Figure 4B and C) . We also noticed that 188 certain small RNAs were more abundant in the Ago-bound fraction when compared to total RNA 189 relative to all other RNAs. To determine whether this type of processing was specific for 190 HCT116 Drosha k.o. cells, we analyzed the Ago-bound small CD95L-derived RNAs in HeyA8 191 CD95 k.o. cells after expression of wt CD95L ( Figure 4D ) and compared them with the total 192 RNA fraction ( Figure 4E ). While we found fewer CD95L-derived reads in these cells, the 193 general location of some of the read clusters overlapped with the ones found in the Drosha k.o. 194 cells and again both the mean and peak of the distribution of RNA lengths was smaller in the 195 Ago-bound fraction versus the total RNA fraction ( Figure 4A, bottom panel) . Together, these 196 data suggest that CD95L mRNA can be processed into smaller RNA fragments, which are then 197 trimmed to a length appropriate for incorporation into the RISC. 198
Our data suggest that the CD95L mRNA, when overexpressed, is toxic to cells due to the 199 formation of Ago-bound small RNAs that are incorporated into the RISC and kill cells through 200 8 processing of CD95L mRNA or loading the small RNAs into the RISC, we expressed 202
MUT NP in wt and Dicer k.o. HCT116 cells ( Figure 4F ). Dicer k.o. cells were still 203 sensitive to toxicity induced by CD95L mRNA expression, suggesting the toxicity of the CD95L 204 mRNA does not require the processing by either Drosha or Dicer. Using custom real-time qPCR 205 primers designed to specifically detect the small RNAs from clusters 8 and 21, we detected, in 206 both wt and Dicer k.o. cells over-expressing CD95L
MUT NP, fragments from these clusters 207 (Figure 4G ), demonstrating that Dicer is not involved in processing CD95L mRNA. 208
All the reported small RNAs derived from CD95L corresponded to the sense strand of the 209 expressed mRNA, raising the question of how they could be processed into double-stranded 210 siRNAs in the absence of an antisense strand. To get a preliminary answer to this question, we 211 subjected the CD95L ORF mRNA sequence to a secondary structure prediction (Figure 4 -212 figure supplement 1A). According to this analysis, the CD95L ORF mRNA forms a tightly 213 folded structure with many of the small RNAs of the 22 clusters juxtaposing each other in stem-214 like structures creating regions of significant complementarity. These may provide the duplexes 215 needed to be processed and loaded into the RISC. Interestingly, many of the juxtaposing reads 216
were found in duplex structures with 3' overhangs. Three of these oligonucleotides (derived from 217 clusters 7, 15 and 22) when expressed as siRNAs were toxic to HeyA8, H460, M565 and 3LL 218 cells (Figure 4 -figure supplement 1B) . 219
In summary, our data suggest that si-and/or shRNAs with certain seed sequences as they are 220 present in CD95 and CD95L and the entire CD95L ORF are toxic to cancer cells. The CD95L 221 mRNA is broken down into small RNA-active fragments that are loaded into the RISC and then 222 target critical survival genes. This results in cell death through 6mer seed toxicity. The process is 223 independent of both Drosha and Dicer. Finally, the data suggest that a high miRNA content, by 224 "filling up" the RISC, might render cells less sensitive to this form of cell death. 225
226

Discussion 227
We recently reported a novel form of cell death that was observed after expression of si/shRNAs 228 designed from the sequences of CD95/CD95L mRNA (Putzbach et al., 2017) . More recently we 229 described that cells die from a loss of multiple survival genes through a mechanism we call 6mer 230 seed toxicity . The most toxic si/shRNAs derived from CD95 or CD95L were 231 found in the ORF of CD95L (Putzbach et al., 2017) . This pointed toward the CD95L mRNA, 232 itself being toxic.
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We now show that expression of full-length CD95L mRNA triggers toxicity that is 234 independent of the protein product and canonical apoptosis. This is intriguing considering 235 previous studies showed transgenic expression of CD95L using viruses killed multiple cancer 236 cells that were completely resistant to CD95 mediated apoptosis after addition of agonist anti-237 A major question that arises from our data is whether CD95L mRNA is toxic in vivo. We and 261 others have noticed upregulation of CD95L in multiple stress-related conditions such as after 262 treatment with chemotherapy ( (Friesen, Fulda, & Debatin, 1999 ) and data not shown). While the 263 amount of CD95L mRNA and the level of upregulation alone may not be enough to be toxic, it 264 could be the combination of multiple RNA fragments, derived from multiple different mRNAs 265 10 that are generated to kill cells would be self-defeating. Therefore, nature likely distributed this mRNA-based toxicity-inducing 272 capacity over many genes in the genome to prevent activating it when any one of those genes is 273 upregulated during specific cellular processes. It is more likely there exists an entire network of 274 these genes that can release toxic small RNAs when the appropriate stimulus is encountered. 275
Consistent with this hypothesis we recently identified other genes that contain sequences that 276 when converted to shRNAs kill cancer cells through 6mer seed toxicity (Patel & Peter, 2017 
Reagents and antibodies 283
All reagents and antibodies were described previously (Putzbach et 
Overexpression of CD95L cDNAs 322
and mutant CD95L cDNAs were generated by seeding cells at 100,000 cells per well in a 6-well 325 plate and infecting cells with lentivirus generated in 293T cells (500 µl viral supernatant per 326 well) with 8 μg/ml Polybrene. Media was changed next day. Selection was started either during 327 the evening of the same day or on following day with 3 μg/ml puromycin. HCT116, HCT116 328 Drosha knockout, and HCT116 Dicer knockout cells (Kim et al., 2016 ) overexpressing CD95L 329 cDNAs were generated by seeding cells at 100,000 cells per well in a 24-well plate or 500,000 330 cells per well in a 6-well plate and infecting cells with lentivirus generated in 293T cells (100 µl 331 virus per 24-well or 500 µl per 6-well) in the presence of 8 μg/ml Polybrene. Media was changed 332 the next day, and cells were selected with 3 μg/ml puromycin the following day. Infection with 333 empty pLenti was always included as a control. 334
To assess toxicity of overexpressing CD95L cDNAs, cells infected with these constructs 335
were plated in on a 96-well plate 1 day after selection in the presence of puromycin (uninfected 336 cells were all dead after 1 day in presence of puromycin); Cell confluency was assessed over 337 time using the IncuCyte as described previously (Putzbach et al., 2017) . 338
To assess overexpression of CD95L cDNAs in apoptosis-sensitive HeyA8 cells in Figure  339 1A, infection with CD95L lentiviruses were done in 96-well plate using 50 µl of virus in the 340 presence of 20 µM zVAD-fmk (Sigma-Aldrich #V116) and 8 μg/ml Polybrene; media was 341 changed next day in the presence of 20 µM zVAD-fmk; 3 μg/ml puromycin was added the 342 following day. Infection with the CD95L constructs for the RT-qPCR and Western blot in 343 Figure 1B were done in a 6-well plate in the presence of 20 µM zVAD-fmk. 344
For the experiment in Figure 3B , HeyA8 CD95 knock-out cells were reverse transfected 345 in a 6-well plate; 100,000 cells were plated in wells with either the On-TargetPlus non-targeting 346 siRNA (Dharmacon #D-001810-10) or siAGO2 pool (Dharmacon ##L-004639-00-0005) at 25 347 nM complexed with 1 µl RNAiMax. After ~24 hrs, the cells were infected with either pLenti or 348 pLenti-CD95L (500 μl of viral supernatant [25% of total volume]). Next day, media was 349 replaced, and cells were expanded to 10 cm plates. The following day, 3 μg/ml puromycin 350 was added. When puromycin selection was complete (one day later), the 750-1,500 cells were 351 plated per well in a 96-well plate and put in the IncuCyte machine to assess cell confluency over 352 time. 
CRISPR deletions 355
We co-transfected a Cas9-expressing plasmid (Jinek et al., 2013) and two gRNAs that target 356 upstream and downstream to delete an entire section of DNA as described previously (Putzbach 357 et al., 2017). The gRNA scaffold was used as described (Mali et al., 2013) . The gRNAs were 358 designed using the algorithm found at http://crispr.mit.edu; only gRNAs with a score above 50 359 were considered. 360
A deletion of 227 nucleotides in exon 4 of CD95 in MCF-7 cells (ΔshR6, clone #21) was 361 generated using gRNAs described previously (Putzbach et 
Real-Time quantitative PCR 376
The relative expression of specific mRNAs was quantified as described previously (Gao et al., 377 2018) . The primer/probes purchased from ThermoFisher Scientific were GAPDH 378 (Hs00266705_g1), human CD95L (Hs00181226_g1 and Hs00181225_m1), human CD95 379 (Hs00531110_m1 and Hs00236330_m1), and a custom primer/probe to detect the CD95L SIL 380 mRNA (designed using the Thermofisher Scientific custom design tool; assay ID: APNKTUD). 381
Custom RT-qPCR probes designed to specifically detect small RNA species were used to 382 detect CD95L fragments in Figure 4G . These probes were designed using ThermoFisher's 383
Custom TaqMan Small RNA Assay Design Tool (https://www.thermofisher.com/order/custom-384 genomic-products/tools/small-rna/) to target the cluster 8 sequence (5'-385 AAGGAGCTGGCAGAACTCCGAGA-3') and the cluster 21 sequence (5'-386 23 TCAACGTATCTGAGCTCTCTC-3'). Detection of these fragments involves a two-step 387 amplification protocol used to detect microRNAs. In the first step, the High-Capacity cDNA 388 reverse transcription kit is used to selectively reverse transcribe the two clusters to be quantified 389 using specific primers and 20 nM RNA input following the manufacturer's protocol. The cDNA 390 is diluted 1:5. The qPCR reaction mixture is composed of the diluted cDNA, the custom probes, 391 and the Taqman Universal PCR Master Mix (Applied Biosystems #43240018). Reactions were 392 performed in triplicate. Ct values were determined using the Applied Biosystems 7500 Real 393
Time PCR system with a thermocycle profile of 50°C for two min (step one), 95°C for 10 min 394 (step two), and then 40 cycles of 95°C for 15 s (step three) and 60°C for 1 min (step four). The 395
ΔΔCt values between the small RNA of interest and the control were calculated to determine 396 relative abundance of the small RNA. Samples were normalized to Z30 (ThermoFisher Scientific 397
#4427975). 398 399
Western blot analysis 400
Detection of human CD95, CD95L and Ago proteins was done via Western blot as described 401 previously (Putzbach et al., 2017) . 402
403
CD95 surface staining 404
Flow cytometry was used to quantify the level of membrane-localized CD95 as described 405 previously (Putzbach et al., 2017) . 406
407
Cell death quantification (DNA fragmentation) and ROS production 408
The percent of subG1 nuclei (fragmented DNA) was determined by PI staining/flow cytometry 409 as described previously (Putzbach et al., 2017) . ROS production was quantified using the cell-410 permeable indicator 2',7'-dichlorodihydrofluorescein diacetate (ThermoFisher Scientific #D399) 411 as previously described (Hadji et al., 2014) . 412
413
Assessing cell growth and fluorescence over time 414
After treatment/infection, cells were seeded in a 96-well plate at least in triplicate. Images were 415 captured at indicated time points using an IncuCyte ZOOM live cell imaging system (Essen 416
BioScience) with a 10x objective lens. Percent confluence and total fluorescent integrated 417 intensity was calculated using the IncuCyte ZOOM software (version 2015A). 418 24 419
Infection of cells for Ago-pull down and small RNA-Seq analysis 420
HeyA8 ΔshR6 clone #11 cells were seeded at 75,000 cells per well on 6-well plates, and the 421 HCT116 and HCT116 Drosha knock-out cells were both seeded at 500,000 per well on 6-well 422 plates. The HeyA8 ΔshR6 clone #11 cells were infected with 0.5 mL of empty pLenti or pLenti-423 CD95L-WT viral supernatant per well. The HCT116 and HCT116 Drosha knockout cells were 424 infected with 0.5 mL empty pLenti or pLenti-CD95L
MUT NP viral supernatant per well. Media 425 was changed the next day and the cells were pooled and expanded to multiple 15 cm dishes. 426
Selection with 3 µg/mL puromycin began the following day. The next day, the HeyA8 ΔshR6 427 clone #11 infected cells were seeded at 600,000 cells per dish in multiple 15 cm dishes; the 428 HCT116 and HCT116 Drosha knock-out cells were seeded at 5 million cells per dish in multiple 429 15 cm dishes. Two days later, each of the samples was pelleted and split in two: one pellet was 430 lysed and processed for small RNA sequencing, and the other pellet was flash frozen in liquid 431 nitrogen. The pellets were stored at -80°C until they could be used for the Ago pull-down 432 experiment. The purpose of splitting the sample was so that we could compare the total cellular 433 pool of small RNAs to the fraction that was bound to the RISC. This way, the processing 434 CD95L-derived fragments from the full-length mRNA in the cytosol to the final mature RISC-435 bound form could be mapped. This was all done in duplicate. 436
437
RNA-Seq analysis 438
Total RNA was isolated using the miRNeasy Mini Kit (Qiagen, #74004) following the 439 manufacturer's instructions. An on-column digestion step using the RNase-free DNase Set 440 (Qiagen #79254) was included. Both small and large mRNA libraries were generated and 441 sequenced as described previously (Putzbach et al., 2017) . Reads were trimmed with TrimGalore 442 and then aligned to the hg38 assembly of the human genome with Tophat. Raw read counts were 443 assigned to genes using HTSeq and differential gene expression was analyzed with the R 444
Bioconductor EdgeR package (Robinson, McCarthy, & Smyth, 2010) . 445
446
Ago pull down and RNA-Seq analysis of bound small RNAs 447
Cell pellets were harvest at 50 hours after plating (122 hours after infection) and were flash 448 frozen in liquid nitrogen. The pellets were stored at -80°C until ready for further processing. 449
Between 10 and 25 x 10 6 cells were lysed in NP40 lysis buffer (20 mM Tris, pH 7.5, 150 mM 450 27 (Promega). The % viability was calculated in relation to the RNAiMAX-only treatment 515 structure (Figure 4 -figure supplement 1B) . 516
517
Statistical analyses 518
Continuous data were summarized as means and standard deviations (except for all IncuCyte 519 experiments where standard errors are shown) and dichotomous data as proportions. Continuous 520 data were compared using t-tests for two independent groups and one-way ANOVA for 3 or 521 more groups. For evaluation of continuous outcomes over time, two-way ANOVA was used with 522 one factor for the treatment conditions of primary interest and a second factor for time treated as 523 a categorical variable to allow for non-linearity. 524
The effects of treatment on wild-type versus Drosha knock-out cells were statistically 525 assessed by fitting regression models that included linear and quadratic terms for value over 526 time, main effects for treatment and cell type, and two-and three-way interactions for treatment, 527 cell-type and time. The three-way interaction on the polynomial terms with treatment and cell 528 type was evaluated for statistical significance since this represents the difference in treatment 529 effects over the course of the experiment for the varying cell types. 530 Figure 2B was performed using the GSEA v2. Genes with an average normalized read expression (across both pair of duplicates) below 3 were 536 excluded so as to only include genes that are truly expressed. The GO enrichment analysis shown 537
GSEA used in
in Figure 2D was performed with all genes that after alignment and normalization were found to 538 be at least 1.5 fold downregulated with an adjusted p-value of <0.05 using the software available 539 on www.Metascape.org and default running parameters. The other data sets used in this analysis 540 (HeyA8 cells transfected with a toxic siRNA targeting CD95L siL3 and 293T infected with toxic 541 shRNAs targeting CD95L shL1 and shL3 and HeyA8 cells infected with a toxic shRNA 542 targeting CD95 shR6) were previously described (Putzbach et al., 2017) . 543
All statistical analyses were conducted in Stata 14 or R 3.3.1. 544 
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